Search Results

Displaying Results 26-46 of 46 "'VEC'"

Feb 05, 2026, 18:30 ET ICYMI: President Signs FY2026 Defense Bill Including $12 Million for National 9/11 Pentagon Memorial Visitor Education Center

Defense Bill, signed into law by President Trump, includes $12 million in federal funding to support the establishment of a Visitor Education Center (VEC) adjacent to the National 9/11 Pentagon Memorial.

More news about: Pentagon Memorial Fund


Feb 04, 2026, 17:31 ET Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

evaluating new oncolytic virus drugs to improve the treatment landscape.Promising pipeline oncolytic virus therapies, such as Pelareorep, Pexa-Vec, CAN-2409, BS001, ParvOryx, Telomelysin, AdAPT-001, VCN-01, LOAd 703, DNX-2401, Surv.m-CRA-1, G207, MVR-T3011, VG161, OrienX010, AloCelyvir, Voyager-V1,

More news about: DelveInsight Business Research, LLP


Feb 04, 2026, 08:00 ET ID.me Appoints Former State Executive and Government Modernization Leader Mitch Melis as Field CTO, Public Sector

and digital transformations of government agencies and services.Most recently he served as Commissioner of the Virginia Employment Commission (VEC), where he led a multi-year turnaround focused on workflow redesign, digital modernization, and trust-based identity integration—improving service delivery,

More news about: ID.me, Inc.


Jan 11, 2026, 15:00 ET REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program

lomparvovec (sura-vec, ABBV-RGX-314) for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR)Sura-vec is being developed in collaboration with AbbVie, and could be the first gene therapy for a non-rare disease, if approved.Sura-vec is on track

More news about: REGENXBIO Inc.


Dec 17, 2025, 05:00 ET Umělá inteligence hledající pravdu vytváří největší encyklopedický portál na světě - šesttisíckrát větší než Wikipedia

v oblasti generativní AI. „Zaměřujeme se na obsah založený na datech a zdrojích s plně ověřeným původem, který uživatelům umožňuje nahlížet na danou věc z co nejvíce úhlů, nikoli pouze z pohledu jednoho potenciálně zaujatého zdroje.Technologie Botipedie se neomezuje na velké jazykové modely (LLM)

More news about: INSEAD


Dec 09, 2025, 08:28 ET Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition

the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. Additionally,

More news about: Eli Lilly and Company


Nov 13, 2025, 11:00 ET Marelli awarded for its new front axle for electric racing vehicles at the Professional MotorSport World Expo 2025

lineup are the company's AI-powered control units, enabling transformative edge intelligence: these include the "VEC-480" – winner of the Innovation of the Year 2024 Award – and the new "VEC-200", which is a compact, high-performance controller with advanced AI, exceptional computing power and high-frequency

More news about: Marelli


Nov 11, 2025, 12:00 ET FranklinWH Named One of the First Approved Battery Partners in Vermont Electric Co-Op's Expanded Energy Storage Program

of the first approved manufacturers in the Vermont Electric Co-op (VEC) Flexible Load battery storage program. The milestone follows VEC's decision to expand its program, offering homeowners better access to reliable, cost-saving

More news about: FranklinWH Energy Storage Inc.


Nov 07, 2025, 06:02 ET 12 Top Press Releases from October

Lilly to Acquire Adverum Biotechnologies Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose.

More news about: PR Newswire


Nov 06, 2025, 07:05 ET REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights

Surabgene lomparvovec (sura-vec, ABBV-RGX-314) on track to be first gene therapy for chronic retinal disease Enrollment completed in pivotal trials evaluating subretinal delivery of sura-vec in wet AMD; topline

More news about: REGENXBIO Inc.


Nov 06, 2025, 00:11 ET Sympózium Pekinskej univerzity uvádza čínsku vojenskú históriu v globálnej perspektíve

toho získali krajania po oboch stranách Taiwanského prielivu príležitosť viesť osobný dialóg s cieľom posilniť jednotu a spoločne presadzovať veľkú vec národného zjednotenia. Tento rok si pripomíname 80. výročie víťazstva v čínskej ľudovej vojne odporu proti japonskej agresii a

More news about: Peking University


Oct 24, 2025, 13:47 ET Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders

per share, totaling potential consideration of $12.47 per share. The contingent value rights provide up to $1.78 per share upon U.S. approval of Ixo-vec within seven years of closing, and up to $7.13 per share if annual worldwide net sales exceed $1 billion within ten years. Adverum

More news about: Ademi LLP


Oct 24, 2025, 08:30 ET Lilly to Acquire Adverum Biotechnologies

About Ixo-vec in Wet AMD Adverum is developing ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), its clinical-stage gene therapy product candidate, for the treatment of wet AMD. Ixo-vec utilizes a proprietary vector capsid,

More news about: Eli Lilly and Company


Oct 14, 2025, 20:44 ET Nová Evropská koalice pro cirkulární textil vyzývá k vytvoření cirkulární textilní ekonomiky: „Svět bez odpadu je možný."

Koalice zdůrazňuje, že takový stav je již neudržitelný. „Odmítáme přijmout textilní odpad jako nevyhnutelnou věc, naopak ho vnímáme jako řešitelnou výzvu naší generace," dočteme se v manifestu. Koalice vyzývá k naléhavým krokům ze strany EU, aby odpovídající

More news about: Reju


Oct 09, 2025, 10:00 ET Trustmi Recognized for Cybersecurity Innovation in 9th Annual CyberSecurity Breakthrough Awards Program

Leveraging behavioral AI, Trustmi enables customers to detect and stop advanced social engineering threats, including BEC, VEC, impersonation, and vendor compromise before funds are transferred. Trustmi's platform monitors the full payment lifecycle, analyzing hundreds of signals

More news about: Trustmi


Oct 09, 2025, 08:37 ET SeoulTech Scientists Develop AI-Based Patent Abstract Generator to Discover and Detail Technology Opportunities

reconstruction of the vacancy coordinates into high-dimensional embedding vectors through decoder, followed by generation of human-readable texts via vec2text. Prof. Lee remarks: "The most revolutionary aspect of our research is its ability to translate abstract patent vacancies

More news about: Seoul National University of Science and Technology


Oct 09, 2025, 07:05 ET REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting

About Surabgene Lomparvovec (sura-vec, ABBV-RGX-314) Sura-vec is being investigated as a potential one-time treatment for wet AMD, diabetic retinopathy and other chronic retinal conditions. Sura-vec consists of the NAV® AAV8 vector, which encodes

More news about: REGENXBIO Inc.


Oct 06, 2025, 07:05 ET REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD

active-controlled trials designed to support the global regulatory submissions of sura-vec. ATMOSPHERE, conducted in the U.S., is evaluating sura-vec versus ranibizumab; ASCENT, conducted in the U.S. and 13 other countries, is evaluating sura-vec versus aflibercept. The primary endpoint is non-inferiority based on

More news about: REGENXBIO Inc.


Sep 11, 2025, 07:35 ET TCL získala na veletrhu IFA 2025 několik ocenění za svá špičkové řešení pro inteligentní bydlení

monitorů. Smartphone TCL NXTPAPER 60 Ultra si díky svým pokročilým displejům šetrným k očím zajistil vítězství v kategorii „Nejlepší technologie pro dobrou věc" a k němu se jako čestný vítěz přidal tablet TCL NXTPAPER 11 Plus. RayNeo X3 Pro se stal čestným vítězem v kategorii „Nejlepší vznikající technologie"

More news about: TCL


Sep 09, 2025, 07:14 ET Hisense získává devět cen IFA Innovation Awards 2025 a znovu potvrzuje své vedení v zobrazovací technice a chytrém bydlení

třídy AAAA a rychlého, udržitelného výkonu při praní i sušení, získala ocenění za sociální dopad v kategorii IFA Tech for Good (Technologie pro dobrou věc). V oblasti designových inovací získaly nejvyšší ocenění Best in Design brýle VIDDA AI Audio Glasses, ocenění Design Honoree si odnáší X-Zone Master

More news about: Hisense


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.